相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preclinical Testing of the Akt Inhibitor Triciribine in T-Cell Acute Lymphoblastic Leukemia
Camilla Evangelisti et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Suppression of leukemia development caused by PTEN loss
Wei Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Non-genomic loss of PTEN function in cancer: not in my genes
Nick R. Leslie et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
The bone marrow microenvironment as a sanctuary for minimal residual disease in CML
Rajesh R. Nair et al.
BIOCHEMICAL PHARMACOLOGY (2010)
The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis
Alberto M. Martelli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Allosteric and ATP-competitive kinase inhibitors of mTOR for cancer treatment
Carlos Garcia-Echeverria
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia
Nicolas Chapuis et al.
BLOOD (2010)
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition
Petra S. Bachmann et al.
BLOOD (2010)
The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation
Alexa S. Green et al.
BLOOD (2010)
Antisense HIF-1α prevents acquired tumor resistance to angiostatin gene therapy
X. Sun et al.
CANCER GENE THERAPY (2010)
Mammalian Target of Rapamycin Activator RHEB Is Frequently Overexpressed in Human Carcinomas and Is Critical and Sufficient for Skin Epithelial Carcinogenesis
Zhi Hong Lu et al.
CANCER RESEARCH (2010)
Activity of the Novel Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 against T-Cell Acute Lymphoblastic Leukemia
Francesca Chiarini et al.
CANCER RESEARCH (2010)
mTOR Activation Induces Tumor Suppressors that Inhibit Leukemogenesis and Deplete Hematopoietic Stem Cells after Pten Deletion
Jae Y. Lee et al.
CELL STEM CELL (2010)
Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia
Nicolas Chapuis et al.
CLINICAL CANCER RESEARCH (2010)
Highly Phosphorylated FOXO3A Is an Adverse Prognostic Factor in Acute Myeloid Leukemia
Steven M. Kornblau et al.
CLINICAL CANCER RESEARCH (2010)
The Bcl-2 Family as a Rational Target for the Treatment of B-Cell Chronic Lymphocytic Leukaemia
N. Capitani et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2-and gamma-secretase inhibitors
Ana Silva et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody
Nicolas Chapuis et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia
Sophie Park et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Ubiquitination of PTEN (Phosphatase and Tensin Homolog) Inhibits Phosphatase Activity and Is Enhanced by Membrane Targeting and Hyperosmotic Stress
Helene Maccario et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells
Lizhi He et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The Bcl-2 Homology Domain 3 Mimetic ABT-737 Targets the Apoptotic Machinery in Acute Lymphoblastic Leukemia Resulting in Synergistic in Vitro and in Vivo Interactions with Established Drugs
Laura M. High et al.
MOLECULAR PHARMACOLOGY (2010)
Lyn Kinase-Dependent Regulation of miR181 and Myeloid Cell Leukemia-1 Expression: Implications for Drug Resistance in Myelogenous Leukemia
Eric I. Zimmerman et al.
MOLECULAR PHARMACOLOGY (2010)
Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies
N. Chapuis et al.
LEUKEMIA (2010)
Relevant mouse model for human monocytic leukemia through Cre/lox-controlled myeloid-specific deletion of PTEN
H. Yu et al.
LEUKEMIA (2010)
The role of Bcl-2 family proteins in chronic lymphocytic leukaemia
Andrea G. S. Buggins et al.
LEUKEMIA RESEARCH (2010)
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
Laura Poliseno et al.
NATURE (2010)
Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia
Konstantinos J. Mavrakis et al.
NATURE CELL BIOLOGY (2010)
The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer
Michelle L. Stewart et al.
NATURE CHEMICAL BIOLOGY (2010)
Subtle variations in Pten dose determine cancer susceptibility
Andrea Alimonti et al.
NATURE GENETICS (2010)
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor
Matthew R. Janes et al.
NATURE MEDICINE (2010)
Drug resistance in mutant FLT3-positive AML
E. Weisberg et al.
ONCOGENE (2010)
Critical roles for mTORC2-and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells
Nathalie Carayol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Identification of the miR-106b∼25 MicroRNA Cluster as a Proto-Oncogenic PTEN-Targeting Intron That Cooperates with Its Host Gene MCM7 in Transformation
Laura Poliseno et al.
SCIENCE SIGNALING (2010)
The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients
Alberto M. Martelli et al.
ONCOTARGET (2010)
The Emerging Role of the Phosphatidylinositol 3-Kinase/ Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology
Alberto M. Martelli et al.
Cancers (2010)
PTEN and the PI3-Kinase Pathway in Cancer
Nader Chalhoub et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance
Kumudha Balakrishnan et al.
BLOOD (2009)
Identification of cancer stem cells in a Tax-transgenic (Tax-Tg) mouse model of adult T-cell leukemia/lymphoma
Jumpei Yamazaki et al.
BLOOD (2009)
Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia
Jerome Tamburini et al.
BLOOD (2009)
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia
Alejandro Gutierrez et al.
BLOOD (2009)
Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin
Sarit Assouline et al.
BLOOD (2009)
Rak Functions as a Tumor Suppressor by Regulating PTEN Protein Stability and Function
Eun-Kyoung Yim et al.
CANCER CELL (2009)
DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival
Timothy R. Peterson et al.
CELL (2009)
Targeting translation in acute myeloid leukemia A new paradigm for therapy?
Jerome Tamburini et al.
CELL CYCLE (2009)
A novel signaling network as a critical rheostat for the biology and maintenance of the normal stem cell and the cancer-initiating cell
Keisuke Ito et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)
Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity
Juxiang Cao et al.
EMBO JOURNAL (2009)
Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia
Alberto M. Martelli et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene-targeted therapeutics
Annette S. Gillings et al.
FEBS JOURNAL (2009)
X-linked Inhibitor of Apoptosis Protein (XIAP) Regulates PTEN Ubiquitination, Content, and Compartmentalization
Celine Van Themsche et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
MCL-1-dependent leukemia cells are more sensitive to chemotherapy than BCL-2-dependent counterparts
Joslyn K. Brunelle et al.
JOURNAL OF CELL BIOLOGY (2009)
Bim-targeted cancer therapy: A link between drug action and underlying molecular changes
Toru Akiyama et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Bone marrow microenvironment and the identification of new targets for myeloma therapy
K. Podar et al.
LEUKEMIA (2009)
Targeting the leukemic stem cell: the Holy Grail of leukemia therapy
N. Misaghian et al.
LEUKEMIA (2009)
Stem Cell Factor SALL4 Represses the Transcriptions of PTEN and SALL1 through an Epigenetic Repressor Complex
Jiayun Lu et al.
PLOS ONE (2009)
Altering Chemosensitivity by Modulating Translation Elongation
Francis Robert et al.
PLOS ONE (2009)
A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN
Meghdad Rahdar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Activation of the PI3K Pathway in Cancer Through Inhibition of PTEN by Exchange Factor P-REX2a
Barry Fine et al.
SCIENCE (2009)
Leukemic challenge unmasks a requirement for PI3K delta in NK cell-mediated tumor surveillance
Eva Zebedin et al.
BLOOD (2008)
Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosis
Claudia Stolz et al.
BLOOD (2008)
Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers
Chris Pepper et al.
BLOOD (2008)
The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies
Luca Paoluzzi et al.
BLOOD (2008)
SALL4 is a key regulator of survival and apoptosis in human leukemic cells
Jianchang Yang et al.
BLOOD (2008)
Effects of lentivirus-mediated HIF-1α knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells
J. Hao et al.
CANCER GENE THERAPY (2008)
The protein phosphatase activity of PTEN regulates Src family kinases and controls glioma migration
Nandini Dey et al.
CANCER RESEARCH (2008)
t-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanism
Abbes Belkhiri et al.
CANCER RESEARCH (2008)
Targeting the eukaryotic translation initiation factor 4E for cancer therapy
Jeremy R. Graff et al.
CANCER RESEARCH (2008)
Synergistic Proapoptotic Activity of Recombinant TRAIL Plus the Akt Inhibitor Perifosine in Acute Myelogenous Leukemia Cells
Pier Luigi Tazzari et al.
CANCER RESEARCH (2008)
Tenets of PTEN tumor suppression
Leonardo Salmena et al.
CELL (2008)
Controlling the cell death mediators Bax and Bak - Puzzles and conundrums
Jamie I. Fletcher et al.
CELL CYCLE (2008)
Akt inactivates ERK causing decreased response to chemotherapeutic drugs in advanced CaP cells
John T. Lee et al.
CELL CYCLE (2008)
Translational control and cancer therapy
Konstantinos J. Mavrakis et al.
CELL CYCLE (2008)
The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance
Mark B. Meads et al.
CLINICAL CANCER RESEARCH (2008)
Tumorigenic activity and therapeutic inhibition of Rheb GTPase
Konstantinos J. Mavrakis et al.
GENES & DEVELOPMENT (2008)
Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events
Caterina Nardella et al.
GENES & DEVELOPMENT (2008)
MYCN regulates oncogenic MicroRNAs in neuroblastoma
Johannes H. Schulte et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability
Ana Silva et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species
Chong Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis
Bora Gurel et al.
MODERN PATHOLOGY (2008)
The forkhead transcription factor FOXO3a increases phosphoinositide-3 kinase/Akt activity in drug-resistant leukemic cells through induction of PIK3CA expression
Rosaline C. -Y. Hui et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells
Rosaline C-Y. Hui et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-cell acute lymphoblastic leukemia
Federica Fala et al.
MOLECULAR PHARMACOLOGY (2008)
The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism
F. Chiarini et al.
LEUKEMIA (2008)
PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML
S. Park et al.
LEUKEMIA (2008)
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia
L. S. Steelman et al.
LEUKEMIA (2008)
PML targeting eradicates quiescent leukaemia-initiating cells
Keisuke Ito et al.
NATURE (2008)
Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors
L. S. Steelman et al.
ONCOGENE (2008)
The role of PTEN signaling perturbations in cancer and in targeted therapy
M. Keniry et al.
ONCOGENE (2008)
The PTEN-PI3K pathway: of feedbacks and cross-talks
A. Carracedo et al.
ONCOGENE (2008)
Post-translational regulation of PTEN
X. Wang et al.
ONCOGENE (2008)
mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization
Boyi Gan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
mTORC1 promotes survival through translational control of Mcl-1
John R. Mills et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Identification of a Small Subpopulation of Candidate Leukemia-Initiating Cells in the Side Population of Patients with Acute Myeloid Leukemia
Bijan Moshaver et al.
STEM CELLS (2008)
Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways
Jerome Tamburini et al.
BLOOD (2008)
New modes of translational control in development, behavior, and disease
Nahum Sonenberg et al.
MOLECULAR CELL (2007)
Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38
Xiaochun Bai et al.
SCIENCE (2007)
The emerging roles of forkhead box (Fox) proteins in cancer
Stephen S. Myatt et al.
NATURE REVIEWS CANCER (2007)
Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain
Leticia Odriozola et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients
Jerome Tamburini et al.
BLOOD (2007)
PTEN is destabilized by phosphorylation on Thr366
Helene Maccario et al.
BIOCHEMICAL JOURNAL (2007)
Foxo3a is essential for maintenance of the hematopoietic stem cell pool
Kana Miyamoto et al.
CELL STEM CELL (2007)
HIF-1-regulated glucose metabolism a key to apoptosis resistance?
Simone Fulda et al.
CELL CYCLE (2007)
Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G
Nathan J. Moerke et al.
CELL (2007)
FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress
Zuzana Tothova et al.
CELL (2007)
Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia
Charlotte V. Cox et al.
BLOOD (2007)
NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN
Xinjiang Wang et al.
CELL (2007)
Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts
P. L. Tazzari et al.
LEUKEMIA (2007)
beta 1 integrin mediated adhesion increases Bim protein degradation and contributes to drug resistance in leukaemia cells
L. A. Hazlehurst et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Syk-dependent mTOR activation in follicular lymphoma cells
Ludivine Leseux et al.
BLOOD (2006)
Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma
Evangelia Peponi et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation
Fumiaki Okahara et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic (vol 103, pg 14907, 2006)
Junya Kuroda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Predicted mechanisms of resistance to mTOR inhibitors
R. T. Kurmasheva et al.
BRITISH JOURNAL OF CANCER (2006)
Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic
Junya Kuroda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A selective inhibitor of the p110δ isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16
C. Billottet et al.
ONCOGENE (2006)
Hypoxia and HIF-1α protect A549 cells from drug-induced apoptosis
S. E. Schnitzer et al.
CELL DEATH AND DIFFERENTIATION (2006)
PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR
Rosa Bernardi et al.
NATURE (2006)
Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo
Hans-Guido Wendel et al.
CANCER RESEARCH (2006)
p53 Down-regulates phosphatase and tensin homologue deleted on chromosome 10 protein stability partially through caspase-mediated degradation in cells with proteasome dysfunction
Yufang Tang et al.
CANCER RESEARCH (2006)
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
Omer H. Yilmaz et al.
NATURE (2006)
Constitutive phosphoinositide 3-kinase activation in acute myeloid leukemia is not due to p110δ mutations
P Cornillet-Lefebvre et al.
LEUKEMIA (2006)
PTEN autoregulates its expression by stabilization of p53 in a phosphatase-independent manner
YF Tang et al.
CANCER RESEARCH (2006)
Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function
XJ Qi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
mTOR•RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes
RC Hresko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Further evidence that ribavirin interacts with eIF4E
A Kentsis et al.
RNA (2005)
Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1
F Chu et al.
CANCER RESEARCH (2005)
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: Tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01
AB Lassman et al.
CLINICAL CANCER RESEARCH (2005)
Cooperative phosphorylation of the tumor suppressor phosphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3β
AM Al-Khouri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
ZB Chen et al.
NATURE (2005)
Essential role for the p110δ isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia
P Sujobert et al.
BLOOD (2005)
A microRNA polycistron as a potential human oncogene
L He et al.
NATURE (2005)
PHLPP: A phosphatase that directly dephosphorylates akt, promotes apoptosis, and suppresses tumor growth
TY Gao et al.
MOLECULAR CELL (2005)
Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells
A Essafi et al.
ONCOGENE (2005)
The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation
I Beuvink et al.
CELL (2005)
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation
YH Yang et al.
EMBO JOURNAL (2005)
Cellular transformation by the MSP58 oncogene is inhibited by its physical interaction with the PTEN tumor suppressor
K Okumura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Roles of fascin in human carcinoma motility and signaling: Prospects for a novel biomarker?
Y Hashimoto et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Transcribed processed pseudogenes in the human genome: an intermediate form of expressed retrosequence lacking protein-coding ability
PM Harrison et al.
NUCLEIC ACIDS RESEARCH (2005)
FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins
B Scheijen et al.
ONCOGENE (2004)
Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression
DC Fingar et al.
ONCOGENE (2004)
Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase
L Mahimainathan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
A Brunet et al.
SCIENCE (2004)
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
HG Wendel et al.
NATURE (2004)
Determinants of rapamycin sensitivity in breast cancer cells
WC Noh et al.
CLINICAL CANCER RESEARCH (2004)
mTOR integrates amino acid- and energy-sensing pathways
C Tokunaga et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap
A Kentsis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The complexity of PTEN: mutation, marker and potential target for therapeutic intervention
LS Steelman et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2004)
Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors
R Kuribara et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors
J Kwon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein
F Okahara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
FoxO3a transcriptional regulation of bim controls apoptosis in paclitaxel-treated breast cancer cell lines
A Sunters et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Constitutive phosphorylation of FKHR transcription factor as a prognostic variable in acute myeloid leukemia
JW Cheong et al.
LEUKEMIA RESEARCH (2003)
JNK/SAPK mediates doxorubicin-induced differentiation and apoptosis in MCF-7 breast cancer cells
J Kim et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Genomic targets of the human c-Myc protein
PC Fernandez et al.
GENES & DEVELOPMENT (2003)
Pathological and molecular aspects of prostate cancer
AM DeMarzo et al.
LANCET (2003)
JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis
K Lei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-Kinase/Akt pathway
BD Manning et al.
MOLECULAR CELL (2002)
4E-binding proteins, the suppressors of eukaryotic initiation factor 4E, are down-regulated in cells with acquired or intrinsic resistance to rapamycin
MB Dilling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression
H Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Downregulation of Bim, a proapoptotic relative of Bcl-2, is a pivotal step in cytokine-initiated survival signaling in murine hematopoietic progenitors
T Shinjyo et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Forkhead transcription factors are targets of signalling by the proto-oncogene PKB (C-AKT)
GJPL Kops et al.
JOURNAL OF ANATOMY (2000)
Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein
S Pugazhenthi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
